172 related articles for article (PubMed ID: 22198631)
1. Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures.
Larré S; Camparo P; Comperat E; Boulbés D; Haddoum M; Baulande S; Soularue P; Costa P; Cussenot O
Asian J Androl; 2012 May; 14(3):499-504. PubMed ID: 22198631
[TBL] [Abstract][Full Text] [Related]
2. [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia].
Santa María Margalef A; Paciucci Barzanti R; Reventós Puigjaner J; Morote Robles J; Thomson Okatsu TM
Arch Esp Urol; 2003 May; 56(4):369-78. PubMed ID: 12830609
[TBL] [Abstract][Full Text] [Related]
3. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo.
Shenouda NS; Sakla MS; Newton LG; Besch-Williford C; Greenberg NM; MacDonald RS; Lubahn DB
Endocrine; 2007 Feb; 31(1):72-81. PubMed ID: 17709901
[TBL] [Abstract][Full Text] [Related]
4. Pygeum africanum extract inhibits proliferation of human cultured prostatic fibroblasts and myofibroblasts.
Boulbès D; Soustelle L; Costa P; Haddoum M; Bali JP; Hollande F; Magous R
BJU Int; 2006 Nov; 98(5):1106-13. PubMed ID: 17034612
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH).
Quiles MT; Arbós MA; Fraga A; de Torres IM; Reventós J; Morote J
Prostate; 2010 Jul; 70(10):1044-53. PubMed ID: 20503393
[TBL] [Abstract][Full Text] [Related]
6. NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.
Papaioannou M; Schleich S; Roell D; Schubert U; Tanner T; Claessens F; Matusch R; Baniahmad A
Invest New Drugs; 2010 Dec; 28(6):729-43. PubMed ID: 19771394
[TBL] [Abstract][Full Text] [Related]
7. Review of the experience and evidence of Pygeum africanum in urological practice.
Salinas-Casado J; Esteban-Fuertes M; Carballido-Rodríguez J; Cozar-Olmo JM
Actas Urol Esp (Engl Ed); 2020; 44(1):9-13. PubMed ID: 31627963
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe.
Breza J; Dzurny O; Borowka A; Hanus T; Petrik R; Blane G; Chadha-Boreham H
Curr Med Res Opin; 1998; 14(3):127-39. PubMed ID: 9787978
[TBL] [Abstract][Full Text] [Related]
9. Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health.
Thompson RQ; Katz D; Sheehan B
J Pharm Biomed Anal; 2019 Jan; 163():162-169. PubMed ID: 30316061
[TBL] [Abstract][Full Text] [Related]
10. Botanical derivatives for the prostate.
Cristoni A; Di Pierro F; Bombardelli E
Fitoterapia; 2000 Aug; 71 Suppl 1():S21-8. PubMed ID: 10930709
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts.
Yablonsky F; Nicolas V; Riffaud JP; Bellamy F
J Urol; 1997 Jun; 157(6):2381-7. PubMed ID: 9146675
[TBL] [Abstract][Full Text] [Related]
12. A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS.
Edgar AD; Levin R; Constantinou CE; Denis L
Neurourol Urodyn; 2007; 26(4):458-463. PubMed ID: 17397059
[TBL] [Abstract][Full Text] [Related]
13. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.
Ishani A; MacDonald R; Nelson D; Rutks I; Wilt TJ
Am J Med; 2000 Dec; 109(8):654-64. PubMed ID: 11099686
[TBL] [Abstract][Full Text] [Related]
14. Phytotherapy for benign prostatic hyperplasia.
Wilt TJ; Ishani A; Rutks I; MacDonald R
Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
[TBL] [Abstract][Full Text] [Related]
15. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens.
Levin RM; Das AK
Urol Res; 2000 Jun; 28(3):201-9. PubMed ID: 10929430
[TBL] [Abstract][Full Text] [Related]
16. Flavonoid and botanical approaches to prostate health.
Katz AE
J Altern Complement Med; 2002 Dec; 8(6):813-21. PubMed ID: 12614534
[TBL] [Abstract][Full Text] [Related]
17. [Tadenan (Pygeum africanum extract) in the treatment of patients with benign prostatic hyperplasia].
Urologiia; 2004; (5):70-2. PubMed ID: 15560171
[No Abstract] [Full Text] [Related]
18. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
[TBL] [Abstract][Full Text] [Related]
19. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
Lee J; Andriole G; Avins A; Crawford ED; Foster H; Kaplan S; Kreder K; Kusek J; McCullough A; McVary K; Meleth S; Naslund M; Nickel JC; Nyberg L; Roehrborn C; Dale Williams O; Barry M
Clin Trials; 2009 Dec; 6(6):628-36. PubMed ID: 20007408
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study].
Barlet A; Albrecht J; Aubert A; Fischer M; Grof F; Grothuesmann HG; Masson JC; Mazeman E; Mermon R; Reichelt H
Wien Klin Wochenschr; 1990 Nov; 102(22):667-73. PubMed ID: 1702916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]